Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

0 avg rating
( 0 ratings by Goodreads )
 
9781468498448: Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)
View all copies of this ISBN edition:
 
 

Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.

"synopsis" may belong to another edition of this title.

From the Back Cover:

The growing evidence that tumors can evade the immune system through a variety of mechanisms makes understanding these processes critical to implementing new and more effective forms of immunotherapy. In Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done, leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors) that may serve as biomarkers for patient prognosis. They discuss the means by which immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells are also outlined.
State-of-the-art and insightful, Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done illuminates the possibilities for developing effective immunotherapies that can block the mechanisms by which tumors evade the immune system in different histologic types of tumors.

Review:

"...good reading for all those interested in oncological immunotherapy." -Cancer Forum

"State of the art and insightful...illuminates the possibilities for developing effective immunotherapies that can block the mechanisms by which tumors evade the immune system in different histologic types of tumors." - Tumori

"About this title" may belong to another edition of this title.

Buy New View Book
List Price: US$ 229.00
US$ 183.62

Convert currency

Shipping: FREE
From United Kingdom to U.S.A.

Destination, rates & speeds

Add to Basket

Other Popular Editions of the Same Title

9781588291837: Cancer Immunotherapy at the Crossroads: How Tumors Evade Immunity and What Can Be Done (Current Clinical Oncology)

Featured Edition

ISBN 10:  1588291839 ISBN 13:  9781588291837
Publisher: Humana Press, 2003
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

Published by Humana Press Inc., United States (2013)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Paperback Quantity Available: 1
Seller:
The Book Depository
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2013. Paperback. Condition: New. Language: English . Brand New Book. Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells. Softcover reprint of the original 1st ed. 2004. Seller Inventory # LIB9781468498448

More information about this seller | Contact this seller

Buy New
US$ 183.62
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

JAMES H. FINKE
Published by Humana Press (2012)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Paperback Quantity Available: 1
Seller:
Herb Tandree Philosophy Books
(Stroud, GLOS, United Kingdom)
Rating
[?]

Book Description Humana Press, 2012. Paperback. Condition: NEW. 9781468498448 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. For all enquiries, please contact Herb Tandree Philosophy Books directly - customer service is our primary goal. Seller Inventory # HTANDREE0835802

More information about this seller | Contact this seller

Buy New
US$ 177.03
Convert currency

Add to Basket

Shipping: US$ 10.42
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Published by Humana Press Inc., United States (2013)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Paperback Quantity Available: 1
Seller:
Book Depository International
(London, United Kingdom)
Rating
[?]

Book Description Humana Press Inc., United States, 2013. Paperback. Condition: New. Language: English . Brand New Book. Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells. Softcover reprint of the original 1st ed. 2004. Seller Inventory # LIB9781468498448

More information about this seller | Contact this seller

Buy New
US$ 188.59
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

James H. Finke
Published by Humana Press Inc. (2012)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Quantity Available: > 20
Print on Demand
Seller:
Pbshop
(Wood Dale, IL, U.S.A.)
Rating
[?]

Book Description Humana Press Inc., 2012. PAP. Condition: New. New Book. Shipped from US within 10 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9781468498448

More information about this seller | Contact this seller

Buy New
US$ 197.11
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds

5.

Finke, James H.
Published by Humana Press (2016)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Paperback Quantity Available: 1
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)
Rating
[?]

Book Description Humana Press, 2016. Paperback. Condition: New. PRINT ON DEMAND Book; New; Publication Year 2016; Not Signed; Fast Shipping from the UK. No. book. Seller Inventory # ria9781468498448_lsuk

More information about this seller | Contact this seller

Buy New
US$ 196.91
Convert currency

Add to Basket

Shipping: US$ 5.03
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

Finke, James H. (Edited by)/ Bukowski, Ronald M. (Edited by)
Published by Humana Press (2013)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Paperback Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)
Rating
[?]

Book Description Humana Press, 2013. Paperback. Condition: Brand New. reprint edition. 408 pages. 9.00x5.90 inches. In Stock. Seller Inventory # x-1468498444

More information about this seller | Contact this seller

Buy New
US$ 232.34
Convert currency

Add to Basket

Shipping: US$ 9.77
From United Kingdom to U.S.A.
Destination, rates & speeds

7.

Published by Humana Press (2012)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Softcover Quantity Available: 1
Seller:
Rating
[?]

Book Description Humana Press, 2012. Condition: New. Seller Inventory # L9781468498448

More information about this seller | Contact this seller

Buy New
US$ 239.87
Convert currency

Add to Basket

Shipping: US$ 3.43
From Germany to U.S.A.
Destination, rates & speeds

8.

James H. Finke
Published by Springer Basel AG Dez 2013 (2013)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Taschenbuch Quantity Available: 1
Seller:
BuchWeltWeit Inh. Ludwig Meier e.K.
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Springer Basel AG Dez 2013, 2013. Taschenbuch. Condition: Neu. Neuware - Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells. 386 pp. Englisch. Seller Inventory # 9781468498448

More information about this seller | Contact this seller

Buy New
US$ 239.87
Convert currency

Add to Basket

Shipping: US$ 19.62
From Germany to U.S.A.
Destination, rates & speeds

9.

James H. Finke
Published by Springer Basel AG Dez 2013 (2013)
ISBN 10: 1468498444 ISBN 13: 9781468498448
New Taschenbuch Quantity Available: 1
Seller:
Rheinberg-Buch
(Bergisch Gladbach, Germany)
Rating
[?]

Book Description Springer Basel AG Dez 2013, 2013. Taschenbuch. Condition: Neu. Neuware - Leading investigators and clinicians detail the different mechanisms used by tumors to escape and impair the immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and antigen-presenting cells (dendritic cells and tumors), that may serve as biomarkers for patient prognosis. They discuss the means by which these immune functions may be protected or restored in order to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients' immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells. 386 pp. Englisch. Seller Inventory # 9781468498448

More information about this seller | Contact this seller

Buy New
US$ 239.87
Convert currency

Add to Basket

Shipping: US$ 19.62
From Germany to U.S.A.
Destination, rates & speeds